In Brief This Week: GenMark, Advanced Liquid Logic, Illumina; Quest, Transgenomic; Cancer Genetics; PerkinElmer, Caliper, Bruker; More | GenomeWeb

NEW YORK (GenomeWeb News) – Following Illumina's purchase of Advanced Liquid Logic in July, GenMark has liquidated its preferred stock investment in ALL but retained its license to the firm's digital microfluidics technology, GenMark said in its Form 10-Q filed with the US Securities and Exchange Commission this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.